Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	49.55B
Revenue (ttm)	18.61B
Net Income (ttm)	1.53B
Shares Out	1.37B
EPS (ttm)	1.12
PE Ratio	32.32
Forward PE	27.76
Dividend	0.50 (1.39%)
Ex-Dividend Date	Jun 30, 2025

Volume	4,022,176
Average Volume	5,548,132
Open	36.13
Previous Close	36.13
Day's Range	35.76 - 36.24
52-Week Range	30.84 - 46.27
Beta	0.20
RSI	37.05
Earnings Date	Aug 30, 2025

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China. The company provides product dosage forms, such as pills, powders, wine preparations, capsules, and oral liquids in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, nourishing and calming, digestive system, pediatrics, wind-dispelling and dampness-removing, orthopedics, five senses, dermatology, psychological, and food and wine. The company was founded in 1997 and is headquartered in...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.